GB2555901B - Method of preparation of a novel stem cell-biocomplex for clinical implantation in periodontal space - Google Patents
Method of preparation of a novel stem cell-biocomplex for clinical implantation in periodontal space Download PDFInfo
- Publication number
- GB2555901B GB2555901B GB1712691.3A GB201712691A GB2555901B GB 2555901 B GB2555901 B GB 2555901B GB 201712691 A GB201712691 A GB 201712691A GB 2555901 B GB2555901 B GB 2555901B
- Authority
- GB
- United Kingdom
- Prior art keywords
- dental implant
- stem cells
- mesenchymal stem
- bio
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title claims description 11
- 238000002513 implantation Methods 0.000 title description 7
- 230000003239 periodontal effect Effects 0.000 title description 7
- 239000004053 dental implant Substances 0.000 claims description 31
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 19
- 210000004027 cell Anatomy 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 9
- 238000010883 osseointegration Methods 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 210000004409 osteocyte Anatomy 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 5
- 238000007605 air drying Methods 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 210000003074 dental pulp Anatomy 0.000 claims description 5
- 230000009023 proprioceptive sensation Effects 0.000 claims description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 210000003954 umbilical cord Anatomy 0.000 claims description 4
- 229910052726 zirconium Inorganic materials 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 210000004748 cultured cell Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 19
- 239000007943 implant Substances 0.000 description 17
- 210000000130 stem cell Anatomy 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 8
- 210000005258 dental pulp stem cell Anatomy 0.000 description 7
- 238000010899 nucleation Methods 0.000 description 4
- 230000001172 regenerating effect Effects 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000010478 bone regeneration Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 102100037241 Endoglin Human genes 0.000 description 1
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
- 108010075704 HLA-A Antigens Proteins 0.000 description 1
- 102000015789 HLA-DP Antigens Human genes 0.000 description 1
- 108010010378 HLA-DP Antigens Proteins 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000881679 Homo sapiens Endoglin Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 description 1
- 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000020339 Spinal injury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 description 1
- 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 210000001909 alveolar process Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002648 chondrogenic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000004416 odontoblast Anatomy 0.000 description 1
- 210000005009 osteogenic cell Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 210000000332 tooth crown Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C13/00—Dental prostheses; Making same
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C13/00—Dental prostheses; Making same
- A61C13/08—Artificial teeth; Making same
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ceramic Engineering (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Description
TITLE
METHOD OF PREPARATION OF A NOVEL STEM CELL-BIOCOMPLEX FOR CLINICAL IMPLANTATION IN PERIODONTAL SPACE
FIELD OF THE INVENTION
The present invention relates to the field of regenerative dentistry, particularly relates to a method of novel cell-implant clinical grade stable biocomplex preparation by seeding or culturing mesenchymal stem cells on to titanium or zirconium or collagen based dental implant materials.
BACKGROUND AND PRIOR ART DISCUSSION
One of the aims of regenerative medicine is to reconstruct tissues through the combination of biomaterials and cells to remodel the damaged sections of the functional human body. The ultimate goal of tissue regeneration is to replace the lost or damaged regions. Stem cell-based tooth engineering is deemed as a promising approach in regenerative dentistry as a model. Dental pulp stem cells (DPSCs) represent a kind of adult cell colony which has the potential of self-renewing and multi-lineage differentiation. These DPSCs seem to be the source of odontoblasts that contribute to the formation of dentin-pulp complex. Some studies have proved that DPSCs are capable of producing dental tissues in vivo including dentin, pulp, and crown-like structures. Whereas other investigations have shown that these stem cells can bring about the formation of bone-like tissues.
Guided tissue regeneration (GTR) is focused on development of hard tissues in addition to the soft tissues for periodontal attachment. At present, guided bone regeneration is predominantly applied in the oral cavity to support new hard tissue growth on an alveolar ridge to allow stable placement of dental implants. Used in conjunction with dental implants and GTR by stem cells, owing to the remarkable advantage of regeneration of only a small amount of tissue is highly beneficial to the patient in the field of periodontal disease management. For decades, successful osseointegration has provided thousands of restorations that maintain normal function in bone disorders. With the increasing need to utilize implants in spinal injuries and cardiac milieu for growing patients and enhance their function to simulate normal physiology and nerve connection, there appears to he an urgent need for bio-implants enriched with live human stem cells that have the trans-differentiation capability to form three (3) critical tissues required for tissue regeneration namely bone, neurons and connective tissue cells.
The cell-implant bio-complexes functional output is considered most optimal for long-term stability and survival of implants. Among the progenitors, mesenchymal stem ceils (MSCs) have been shown to be a very promising cell type with their clinically proven trans-differentiation capacities in to lineages. The sources of MSCs are numerous, hut the choice of clinically significant source for harvesting with good yield expressing the retained characteristic markers profile would aid the implantation procedure to overcome the issues with cell number and density of seeding. Human umbilical cord tissue is one of the richest sources of clinical grade progenitor mesenchymal cells. The flow cytometric analysis of these MSCs revealed that the cells are positive for CD29, CD44, CD71, CD73, CD90, and CD105. Furthermore, these cells expressed HLA-A, B, C (MHC-I), hut not HLA-DP, DQ, DR (MHC-Π), or co-stimulatory molecules such as CD80 and CD86. The cultured MSCs from cord tissue were shown to possess potential to differentiate into adipogenic, osteogenic and chondrogenic lineages in vitro upon induction along with meseodermal lineage specific cell types. The same cells were shown ideal seed cells for bone tissue engineering as well.
The technology of dental implants has advanced rapidly in recent years to provide a solution to the aesthetic, functionality and health issues resulting from missing teeth. But conventional dental implants are not the perfect solution for replacing missing teeth as the healing process extends for many months and rejection of the implant occurs in about five percent (5%) of patients. Despite much advancement in implant technology conventional implants do not provide a truly permanent solution for periodontal integration a missing tooth. But the answer could lie in a highly researched new dental technique - stem cell dental implants biocomplexes which could well be the future of implant dentistry accelerating the osseointegration and propiception at the site.
Guided bone regeneration (GBR) encourages new bone growth to replace areas of damage and can be used alongside guided tissue regeneration (GTR) to rebuild soft tissue in a patient’s body. The technologies and practices behind these techniques are subject to constant refinement, and clinical studies examined the possible application of these techniques to other regions of the body. GBR involved epithelial and connective tissue exclusion and space creation to allow the cells of the odontal ligament to repopulate the root surface and to allow bone cells to grow into the area of the defect. US20090208907 entitled “Dental Implant” discloses a cylinder-shaped dental implant comprising a titanium-made base provided with a cavity for a porous structure and a canal for administering medications, used for two-stage implantation into the alveolar bone. This invention makes it possible to create the conditions for successful ingrowth of bone and soft tissues into the implant obtainable by the best ingrowth of the bone tissues into the internal porous structure and the soft tissue ingrowth into a surface porous 3D structure in the area of the alveolar bone. US 20100098670 entitled “Autologous dental pulp stem cell-based bone graft substitute” discloses a method for promoting the differentiation of dental pulp stem cells into osteogenic cells in vitro by contacting the dental pulp stem cells with a biocompatible calcified substrate having a collagen mimetic deposited thereon in a predetermined amount. US20150196371 entitled “Endosseous dental implant assembly” discloses a dental implant assembly comprising a dental implant comprising an abutment portion for connecting to a tooth crown and a hollow base portion defining a cavity therein, said abutment portion integrally with said hollow base portion and a bio-supportive or biodegradable scaffold carried by said hollow base portion of the dental implant wherein the scaffold is impregnated with regenerative stem cells, growth factor or bone graft material.
Although spinal (Biomaterials 23 (2002) 3369-3376) biodegradable implants and implantable cardioverter defibrillator have been in clinical practice, impregnating stem cells in the implants for guided regeneration of the damaged tissue is a new and logical direction owing to the ability of clinical grade stem cells to regenerate the damaged tissue after implantation and the implants already in clinical practice.
SUMMARY OF THE INVENTION
The main objective of the present invention is to prepare a novel progenitor cell-implant by seeding or culturing mesenchymal stem cells on to an inorganic and synthetic implant material biologically active and dynamic with live stem cells impregnated in it which will be useful for the purposes of clinical implantation in periodontal space enhancing osseointegration and propioception. Accordingly, the present invention provides a method of preparation of a bio complex dental implant enhancing osseointegration and proprioception in repaired tissue, comprising the steps of: (a) Culturing and expanding mesenchymal stem cells as per the method described in WO 2014/135949 (corresponding Indian Application No: 932/CHE/2013, published as 32/2015), the relevant portion of which is herein incorporated by reference; (b) Trypsinizing the cultured mesenchymal stem cells that are attached to an adherent plate surface; (c) Pelleting and reconstituting cells in sterile culture expanded osteocytes extract; (d) Coating dental implant surface with reconstituted mixture at room temperature ; and (e) Air drying the bio complex obtained for 2 minutes at room temperature in the class 100 cabinet to attain stability.
Accordingly, the present invention provides a method of preparation of bio complex dental implant enhancing osseointegration and proprioception in repaired tissue, comprising the steps of: (a) Culturing and expanding mesenchymal stem cells as per the method as described in WO 2014/135949 (corresponding Indian Application No: 932/CHE/2013, published as 32/2015), the relevant portion of which is herein incorporated by reference; (b) Trypsinizing the cultured mesenchymal stem cells that are attached to an adherent plate surface; (c) Pelleting and reconstituting cells in autologous protein rich plasma; (d) Coating dental implant surface with reconstituted mixture at room temperature; and (d) Air drying the bio complex obtained for 2 minutes at room temperature in the class 100 cabinet to attain stability.
Accordingly, the present invention discloses a method of preparing such a novel stem cell implant complex derived from human umbilical cord, dental pulp, adipose and stromal tissues by seeding or culturing mesenchymal stem cells on to titanium or zirconium or collagen based dental implant materials. The method of preparation of such implant 100 comprising the steps of: harvesting any mesenchymal stem cells 101 as described in WO 2014/135949 (corresponding Indian Application No: 932/CHE/2013, published as 32/2015), the relevant portion of which is herein incorporated by reference; trypsinizing the attached mesenchymal stem cells from the adherent plate surface upto 10 million; pelleting down 10 million mesenchymal stem cells and reconstituting it in 500 micro litres of sterile culture expanded osteocytes extract or autologous plasma rich plasma 102; coating dental implant surface (3 mm) with 500 micro litres of 10 million cells at room temperature in 3 minutes by dispensing the solution in 3 layers superimposed 103; air drying the complex for 2 minutes at room temperature in the class 100 cabinet, to attain stability 104. The obtained bio-complex is applied surgically into the periodontal space 105.
BRIEF DESCRIPTION OF THE DRAWINGS
For a more complete understanding of the embodiments of the present invention, reference is now made to the following description taken in connection with the accompanying in which:
Figure 1 illustrates a flowchart describing the steps involved in the preparation of the active biocomplex 100.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Reference will now be made in detail to exemplary embodiments and methods of the present invention as illustrated in the accompanying drawings, in which like reference characters designate like or corresponding parts throughout the drawings. It should be noted, however, that the invention in its broader aspects is not limited to the specific details, representative devise and methods and illustrative examples shown and described in connection with the exemplary embodiments and methods.
The clinical research conducted in this invention particularly concentrates on the MSCs derived from cord tissues and dental pulp. This method does not involve surgery or any in-vivo operational activities to collect the above mentioned tissues rather; they are collected form the discarded tissues or donated by a consented donor. The MSCs both from cord tissues and dental pulp, in equal proportion are isolated, cultured and expanded by the novel method as described in WO 2014/135949 (corresponding Indian Application No: 932/CHE/2013, published as 32/2015), the relevant portion of which is herein incorporated by reference.
Figure 1 shows the flow chart illustrating the steps involved in the preparation of the bio complex/ dental implant surgically placed in the tooth cavity for regeneration of dental tissues. The method of preparation such bio complex 100 comprises the following steps. Initially, the mesenchymal stem cells selected from the group comprising of human umbilical cord, dental pulp, adipose and other stromal tissues are culture expanded 101 as described in WO 2014/135949 (corresponding Indian Application No: 932/CHE/2013, published as 32/2015), the relevant portion of which is herein incorporated by reference. 10 million culture harvested MSCs are reconstituted in 500 micro litre of sterile culture expanded osteocytes extract or autologous protein rich plasma 102. Further the reconstituted cells are seeded or coated on dental implant surface made of titanium, zirconium and collagen based dental implant materials 103. Finally the obtained bio complex is air dried for 2 minutes in the room temperature 104 and the same shall be used to replace in the dental socket through surgical method 105.
The above performed method for producing a biocomplex makes the inert material bioactive which in turn makes the material catalyzing osseointegration and propioception in the microenvironment of periodontal socket, which is the invention step involved in the present invention. 10 million mesenchymal stem cell concentration is seeded or coated on 3 mm dental implant surface ratio in order to make it bio active when place in the dental cavity.
Example 1
The patient's left side was chosen as the test side. The surgical procedure was carried out under local anesthesia containing 2% lignocaine hydrochloride in 1:100,000 epinephrine. The biocomplex was placed at the osteotomy site with IF of 40 N cm and measured twice from two different angles, around 90 degrees and parallel to the crestalline. The two measurements buccolingually and mesiodistally are recorded and an average of both the values were taken on record. Patient safety evaluation in terms of unusual pain, swelling, allergic reaction, inflammation, outgrowth observed for 2 weeks post implantation was recorded to be negative while biocomplex stability measurements with Ostell ISQ device was recorded as >70.
Claims (8)
1. A method of preparation of a bio complex dental implant enhancing osseointegration and proprioception in repaired tissue (100), comprising the steps of: a. Culturing and expanding mesenchymal stem cells (101); b. Trypsinizing the cultured mesenchymal stem cells that are attached to an adherent plate surface; c. Pelleting and reconstituting cells in sterile culture expanded osteocytes extract (102); d. Coating dental implant surface with reconstituted mixture at room temperature (103); and e. Air drying the bio complex obtained for 2 minutes at room temperature to attain stability (104).
2. A method of preparation of bio complex dental implant enhancing osseointegration and proprioception in repaired tissue (100), comprising the steps of: a. Culturing and expanding mesenchymal stem cells (101); b. Trypsinizing the cultured mesenchymal stem cells that are attached to an adherent plate surface; c. Pelleting and reconstituting cells in autologous protein rich plasma (102); d. Coating dental implant surface with reconstituted mixture at room temperature (103); and e. Air drying the bio complex obtained for 2 minutes at room temperature to attain stability (104).
3. The method according to claims 1 and 2, wherein the mesenchymal stem cells for culturing are selected from a group comprising of human umbilical cord, dental pulp, adipose and stromal tissues.
4. The method according to claims 1 and 2, wherein the dental implant surface is made of a material selected from a group comprising of titanium, zirconium, and collagen based materials.
5. The method according to claims 1 and 2, wherein it includes trypsinizing, pelleting and reconstituting 100 million mesenchymal stem cells in 500 micro litres of sterile culture expanded osteocytes extract or autologous plasma rich plasma.
6. The method according to claims 1 and 2, wherein it includes coating 3mm of a dental implant surface with 10 million reconstituted cells at room temperature in 3 minutes by dispensing the solution in 3 layers superimposed.
7. A bio-complex dental implant for enhancing osseointegration and proprioception in repaired tissue comprising a bio inactive dental implant coated with superimposed layers of reconstituted culture expanded mesenchymal stem cells.
8. A bio-complex dental implant according to claim 7, wherein the cultured cells are reconstituted in sterile culture expanded osteocytes extract or autologous plasma rich plasma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201643029152 | 2016-08-26 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB201712691D0 GB201712691D0 (en) | 2017-09-20 |
| GB2555901A GB2555901A (en) | 2018-05-16 |
| GB2555901B true GB2555901B (en) | 2019-11-13 |
Family
ID=59894797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1712691.3A Active GB2555901B (en) | 2016-08-26 | 2017-08-08 | Method of preparation of a novel stem cell-biocomplex for clinical implantation in periodontal space |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2555901B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100602858B1 (en) * | 1998-10-13 | 2006-07-20 | 소시에떼 아노님 나뛰랄 엥쁠랑 | Method and apparatus for manufacturing dental implant by impregnation in mesenchymal cell culture |
| EP1767617A1 (en) * | 2005-09-26 | 2007-03-28 | Letizia Mazzini | Mesenchymal stem cells isolation and expansion method and uses thereof |
| US20140356797A1 (en) * | 2012-02-01 | 2014-12-04 | Organ Technologies, Inc. | Dental implant and method for producing same |
-
2017
- 2017-08-08 GB GB1712691.3A patent/GB2555901B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100602858B1 (en) * | 1998-10-13 | 2006-07-20 | 소시에떼 아노님 나뛰랄 엥쁠랑 | Method and apparatus for manufacturing dental implant by impregnation in mesenchymal cell culture |
| EP1767617A1 (en) * | 2005-09-26 | 2007-03-28 | Letizia Mazzini | Mesenchymal stem cells isolation and expansion method and uses thereof |
| US20140356797A1 (en) * | 2012-02-01 | 2014-12-04 | Organ Technologies, Inc. | Dental implant and method for producing same |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2555901A (en) | 2018-05-16 |
| GB201712691D0 (en) | 2017-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6911202B2 (en) | Cosmetic repair using cartilage producing cells and medical implants coated therewith | |
| JP5408578B2 (en) | Composition for autologous or allogeneic transplantation using dental pulp stem cells and use thereof | |
| Liu et al. | Application of dental pulp stem cells in oral maxillofacial tissue engineering | |
| Mao | Stem cells and the future of dental care | |
| US6589525B2 (en) | Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells | |
| WO2007129453A1 (en) | Composition for regeneration of periodontal soft tissue and method for producing the same | |
| US10603410B2 (en) | Complex of implant and cultured periodontal ligament cell sheet, method for manufacturing the same, and method for using the same | |
| CN110464510B (en) | Mandibular reconstruction bracket | |
| Sándor et al. | Combining adipose-derived stem cells, resorbable scaffolds and growth factors: An overview of tissue engineering | |
| RU2320285C2 (en) | Method for restoring alveolar jaw bone crest and periodontium tissues having reduced recovery potential | |
| GB2555901B (en) | Method of preparation of a novel stem cell-biocomplex for clinical implantation in periodontal space | |
| US20130166040A1 (en) | Reagents and methods for preparing teeth for implantation | |
| CN107280789A (en) | A kind of tooth implant | |
| JP2004357567A (en) | Method for regenerating tooth germ | |
| RU2785189C1 (en) | Method for treating gum recession using multipotent mesenchymal stem cells | |
| Sencimen et al. | Implant retained auricular prostheses | |
| Graziano et al. | Sinus lift augmentation using pulp stem cells: A case report and histological evaluation | |
| Kaushik et al. | STEM CELL-BASED REGENERATIVE PROSTHODONTICS. | |
| Ueda | Applied Tissue Engineering | |
| Ahmed et al. | Tissue Engineering in Dentistry-Boom in Dentistry | |
| Sagar et al. | ROLE OF STEM CELLS IN" REGENERATIVE PROSTHODONTICS". | |
| Lee | Characteristics of Alveolar Bone Marrow Cells from Patients Undergoing Dental Extractions or Dental Implant Therapy | |
| Brunelli et al. | Sinus lift augmentation using autologous pulp stem cells: Case report of bone density evaluation | |
| PASSI et al. | Stem cells in dental and maxillofacial surgery: An overview | |
| CN117504008A (en) | An autologous fibrin gel scaffold and its preparation method and application |